| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-17 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |